These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein. Specht B, Bartetzko N, Hohoff C, Kuhl H, Franke R, Börchers T, Spener F. J Biol Chem; 1996 Aug 16; 271(33):19943-9. PubMed ID: 8702709 [Abstract] [Full Text] [Related]
6. Fatty acid binding protein isoforms: structure and function. Schroeder F, Jolly CA, Cho TH, Frolov A. Chem Phys Lipids; 1998 Mar 16; 92(1):1-25. PubMed ID: 9631535 [Abstract] [Full Text] [Related]
7. Modulation of the beta-adrenergic-response in cultured rat heart cells. II. Mammary-derived growth inhibitor (MDGI) blocks induction of beta-adrenergic supersensitivity. Dissociation from lipid-binding activity of MDGI. Wallukat G, Boehmer FD, Engstroem U, Langen P, Hollenberg M, Behlke J, Kuehn H, Grosse R. Mol Cell Biochem; 1991 Mar 27; 102(1):49-60. PubMed ID: 1646956 [Abstract] [Full Text] [Related]
18. Deletion of the gene encoding H-FABP/MDGI has no overt effects in the mammary gland. Clark AJ, Neil C, Gusterson B, McWhir J, Binas B. Transgenic Res; 2000 Dec 05; 9(6):439-44. PubMed ID: 11206972 [Abstract] [Full Text] [Related]